|
Jul 24
|
Defence Therapeutics Granted CNRI-H from the Canadian Nuclear Laboratories to Accelerate the Development of Its Radio-Immuno-Conjugates Program
|
|
Jun 25
|
Defence's ARM-X Anti-Cancer Vaccine Inhibits Growth of Pre-Established Ovarian Cancer Resulting in Complete Responses in Treated Animals
|
|
Jan 13
|
Defence Begins Trading on the OTCQB and Arranges Financing
|
|
Jan 10
|
Defence's AccuTOX(R) Impairs Lung Cancer Growth
|
|
Jul 18
|
Defence Successfully Completes the First Milestone of Its Collaboration Agreement with Orano
|
|
Apr 27
|
USPTO Grants Trademark Registration for Defence Therapeutics(R)
|